MACROPHAGE PHARMA LTD has a total of 33 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2006. It filed its patents most often in Australia, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GENOSCO, NEUROSCIENZE S C A R L and PIMERA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Israel | 3 | |
#4 | United Kingdom | 2 | |
#5 | Hungary | 2 | |
#6 | Serbia | 2 | |
#7 | Russian Federation | 2 | |
#8 | Singapore | 2 | |
#9 | United States | 2 | |
#10 | Brazil | 1 | |
#11 | Canada | 1 | |
#12 | China | 1 | |
#13 | Republic of Korea | 1 | |
#14 | Mexico | 1 | |
#15 | New Zealand | 1 | |
#16 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Moffat David Festus Charles | 19 |
#2 | Davies Stephen John | 11 |
#3 | Anderton Stephen Mark | 8 |
#4 | Perry Martin John | 8 |
#5 | Doris Clare Louise | 8 |
#6 | Pintat Stéphane | 8 |
#7 | Pintat Stephane | 6 |
#8 | Davies Stephen | 4 |
#9 | Pintet Stefan | 2 |
#10 | Moffat Devid Festus Charlz | 2 |
Publication | Filing date | Title |
---|---|---|
GB201908147D0 | New compounds | |
GB201713975D0 | Medical use | |
AU2007246869A1 | p38 MAP kinase inhibitors |